Featuring perspectives from Dr Jennifer R Brown and Prof Paolo Ghia, including the following topics:
- Introduction: The Chronic Lymphocytic Leukemia (CLL) Experience — 2000 to 2025 (0:00)
- Current Therapy Options with Covalent Bruton Tyrosine Kinase (BTK) Inhibitors (9:42)
- Role of Venetoclax in the Treatment of CLL (26:52)
- AMPLIFY Trial and Other Novel BTK Inhibitor and Bcl-2 Inhibitor Combination Strategies (32:29)
- Noncovalent BTK Inhibitor Pirtobrutinib (46:47)
- CAR T-Cell Therapy; Novel Agents (56:12)
CME information and select publications